BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16177353)

  • 1. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
    Maira-Litrán T; Kropec A; Goldmann DA; Pier GB
    Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
    Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
    PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens.
    Gening ML; Maira-Litrán T; Kropec A; Skurnik D; Grout M; Tsvetkov YE; Nifantiev NE; Pier GB
    Infect Immun; 2010 Feb; 78(2):764-72. PubMed ID: 19948836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine.
    Cerca N; Jefferson KK; Maira-Litrán T; Pier DB; Kelly-Quintos C; Goldmann DA; Azeredo J; Pier GB
    Infect Immun; 2007 Jul; 75(7):3406-13. PubMed ID: 17470540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of epitope specificity in the human opsonic antibody response to the staphylococcal surface polysaccharide poly N-acetyl glucosamine.
    Kelly-Quintos C; Kropec A; Briggs S; Ordonez CL; Goldmann DA; Pier GB
    J Infect Dis; 2005 Dec; 192(11):2012-9. PubMed ID: 16267775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.
    Skurnik D; Kropec A; Roux D; Theilacker C; Huebner J; Pier GB
    Clin Infect Dis; 2012 Nov; 55(9):1188-97. PubMed ID: 22806596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies.
    Stevenson TC; Cywes-Bentley C; Moeller TD; Weyant KB; Putnam D; Chang YF; Jones BD; Pier GB; DeLisa MP
    Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3106-E3115. PubMed ID: 29555731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.
    Skurnik D; Merighi M; Grout M; Gadjeva M; Maira-Litran T; Ericsson M; Goldmann DA; Huang SS; Datta R; Lee JC; Pier GB
    J Clin Invest; 2010 Sep; 120(9):3220-33. PubMed ID: 20739753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.
    Lu X; Skurnik D; Pozzi C; Roux D; Cywes-Bentley C; Ritchie JM; Munera D; Gening ML; Tsvetkov YE; Nifantiev NE; Waldor MK; Pier GB
    mBio; 2014 Mar; 5(2):e00974-14. PubMed ID: 24667709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.
    Pozzi C; Wilk K; Lee JC; Gening M; Nifantiev N; Pier GB
    PLoS One; 2012; 7(10):e46648. PubMed ID: 23077517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates.
    Park S; Gerber S; Lee JC
    Infect Immun; 2014 Dec; 82(12):5049-55. PubMed ID: 25245803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens.
    Cywes-Bentley C; Skurnik D; Zaidi T; Roux D; Deoliveira RB; Garrett WS; Lu X; O'Malley J; Kinzel K; Zaidi T; Rey A; Perrin C; Fichorova RN; Kayatani AK; Maira-Litràn T; Gening ML; Tsvetkov YE; Nifantiev NE; Bakaletz LO; Pelton SI; Golenbock DT; Pier GB
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):E2209-18. PubMed ID: 23716675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-Acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide.
    Scully IL; Pavliak V; Timofeyeva Y; Liu Y; Singer C; Anderson AS
    Hum Vaccin Immunother; 2018 Jan; 14(1):81-84. PubMed ID: 29182428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state.
    Cerca N; Jefferson KK; Oliveira R; Pier GB; Azeredo J
    Infect Immun; 2006 Aug; 74(8):4849-55. PubMed ID: 16861673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine.
    Kelly-Quintos C; Cavacini LA; Posner MR; Goldmann D; Pier GB
    Infect Immun; 2006 May; 74(5):2742-50. PubMed ID: 16622211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus.
    Rozalska B; Wadström T
    Scand J Immunol; 1993 May; 37(5):575-80. PubMed ID: 8484103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly-
    Soliman C; Walduck AK; Yuriev E; Richards JS; Cywes-Bentley C; Pier GB; Ramsland PA
    J Biol Chem; 2018 Apr; 293(14):5079-5089. PubMed ID: 29449370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis.
    Mellata M; Mitchell NM; Schödel F; Curtiss R; Pier GB
    Vaccine; 2016 Jan; 34(5):656-662. PubMed ID: 26707217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide.
    Cerca N; Maira-Litrán T; Jefferson KK; Grout M; Goldmann DA; Pier GB
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7528-33. PubMed ID: 17446272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.